The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site
Open accessAbstract
A majority of cutaneous melanomas show activating mutations in the NRAS or BRAF proto‐oncogenes, components of the Ras‐Raf‐Mek‐Erk signal transduction pathway. Consistent data demonstrate the early appearance, in a mutually exclusive manner, of these mutations. The purpose of this paper is to summarize the literature on NRAS and BRAF activating mutations in melanoma tumors with respect to available data on histogenetic classification as well as body site and presumed UV‐exposure. Common alterations of the signal transducing network seem to represent molecular hallmarks of cutaneous melanomas and therefore should continue to strongly stimulate design and testing of targeted molecular interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Somatic Activation of KIT in Distinct Subtypes of Melanoma
Curtin, J. A., Busam, K., Pinkel, D., & Bastian, B. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2984 · Cited by 1,616
A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants
Trahey, M., & McCormick, F. (1987) · Science · doi:10.1126/science.2821624 · Cited by 1,211
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Melanoma and sun exposure: An overview of published studies
Elwood, J. M., & Jopson, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r · Cited by 791
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
The Raf/MEK/ERK pathway: new concepts of activation
Peyssonnaux, C., & Eychène, A. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01125-x · Cited by 735
Determinants of BRAF Mutations in Primary Melanomas
Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664 · cited 4×
“…al., 1994, Jafari et al., 1995, van Elsas et al., 1996, Jiveskog et al., 1998, Demunter et al., 2001a,b, Omholt et al., 2002, Omholt et al., 2003, Maldonado et al., 2003, Deichmann et al., 2004, Reifenberger et al.; 2004, Thomas et al., 2005, Akslen et al., 2005, Lang and MacKie, 2005, Curtin et…”
BackgroundInfluentialGenetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 467
Suppression of BRAF(V599E) in human melanoma abrogates transformation.
Hingorani, S. R., Jacobetz, M. A., Robertson, G. P., Herlyn, M., & Tuveson, D. A. (2003) · PubMed · Cited by 455
Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 445
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Omholt, K., Platz, A., Kanter, L., Ringborg, U. K., & Hansson, J. (2003) · PubMed · Cited by 399
Self-citationExamination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous Melanoma
Goel, V. K., Lazar, A. J. F., Warneke, C. L., Redston, M. S., & Haluska, F. G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700026 · Cited by 392
MC1R Germline Variants Confer Risk for BRAF -Mutant Melanoma
Landi, M. T., Bauer, J., Pfeiffer, R. M., Elder, D. E., Hulley, B., Minghetti, P., Calista, D., Kanetsky, P. A., Pinkel, D., & Bastian, B. C. (2006) · Science · doi:10.1126/science.1127515 · Cited by 346
V599EB-RAF is an Oncogene in Melanocytes
Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C. J., & Marais, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3433 · Cited by 344
Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
Albino, A. P., Strange, R. L., Oliff, A. I., Furth, M. E., & Old, L. J. (1984) · Nature · doi:10.1038/308069a0 · Cited by 324
Edlundh-Rose, E., Egyha??zi, S., Omholt, K., Mansson-Brahme, E., Platz, A., Hansson, J., & Lundeberg, J. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000232300.22032.86 · Cited by 318
Self-citationBRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong, J., Phelps, R. G., Qiao, R., Yao, S., Benard, O., Ronai, Z. A., & Aaronson, S. A. (2003) · PubMed · Cited by 310
Dumaz, N., Hayward, R., Martin, J., Ogilvie, L., Hedley, D., Curtin, J. A., Bastian, B. C., Springer, C., & Marais, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4227 · Cited by 304
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky, G. A., Chenette, E. J., & Der, C. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.014 · Cited by 300
Houben, R., Becker, J. C., Kappel, A., Terheyden, P. A. M., Bröcker, E., Goetz, R., & Rapp, U. R. (2004) · Journal of Carcinogenesis · doi:10.1186/1477-3163-3-6 · Cited by 294
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
van 't Veer, L. J., Burgering, B. M., Versteeg, R., Boot, A. J., Ruiter, D. J., Osanto, S., Schrier, P. I., & Bos, J. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3114 · Cited by 283
Martin, G. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00216-2 · Cited by 281
Meier, F. (2005) · Frontiers in Bioscience · doi:10.2741/1755 · Cited by 267
Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants
Hocker, T., & Tsao, H. (2007) · Human Mutation · doi:10.1002/humu.20481 · Cited by 257
BRAF and NRAS mutations in melanoma and melanocytic nevi
Poynter, J. N., Elder, J. T., Fullen, D. R., Nair, R. P., Soengas, M. S., Johnson, T. M., Redman, B., Thomas, N. E., & Gruber, S. B. (2006) · Melanoma Research · doi:10.1097/01.cmr.0000222600.73179.f3 · Cited by 245
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
Zhang, B.-H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5429 · Cited by 245
RAS Mutations in Human Melanoma: A Marker of Malignant Progression
Ball, N. J., Yohn, J. J., Morelli, J. G., Norris, D. A., Golitz, L. E., & Hoeffler, J. P. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371783 · Cited by 221
Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.
Gorden, A., Osman, I., Gai, W., He, D., Huang, W., Davidson, A., Houghton, A. N., BUSAM, K. J., & Polsky, D. (2003) · PubMed · Cited by 212
Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous Melanomas
Shinozaki, M., Fujimoto, A., Morton, D. L., & Hoon, D. S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1169-3 · Cited by 212
Albino, A. P., Nanus, D. M., Mentle, I. R., Cordon‐Cardo, C., McNutt, N. S., Bressler, J., & Andreeff, M. (1989) · PubMed · Cited by 212
BRAF alterations are associated with complex mutational profiles in malignant melanoma
Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G. D., Perrone, F., Luoni, C., Suardi, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207780 · Cited by 210
Absence of BRAF and NRAS mutations in uveal melanoma.
Cruz, F., Rubin, B. P., Wilson, D. J., Town, A., Schroeder, A., Haley, A., Bainbridge, T., Heinrich, M. C., & Corless, C. L. (2003) · PubMed · Cited by 208
BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
Kumar, R., Angelini, S., Czene, K., Sauroja, I., Hahka‐Kemppinen, M., Pyrhönen, S. O., & Hemminki, K. (2003) · PubMed · Cited by 205
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations
Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 198
Absence of BRAF mutations in UV-protected mucosal melanomas
Edwards, R. H., Ward, M. R., Wu, H., Medina, C. A., Brose, M. S., Volpe, P., Nussen-Lee, S., Haupt, H. M., Martin, A. M., Herlyn, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016667 · Cited by 178
Analysis of N- and K-Ras Mutations in the Distinctive Tumor Progression Phases of Melanoma
Stas, M., Degreef, H., Demunter, A., De Wolf-Peeters, C., & van den Oord, J. J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01601.x · Cited by 176
The specificity of p53 mutation spectra in sunlight induced human cancers
Daya-Grosjean, L., Dumaz, N., & Sarasin, A. (1995) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(95)07130-t · Cited by 164
van Elsas, A., Zerp, S. F., van der Flier, S., Krüse, K. M., Aarnoudse, C. A., Hayward, N. K., Ruiter, D. J., & Schrier, P. I. (1996) · Europe PMC (PubMed Central) · Cited by 160
A genome-based strategy uncovers frequent BRAF mutations in melanoma
Pollock, P. M., & Meltzer, P. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00089-2 · Cited by 160
Jiveskog, S., Ragnarsson-Olding, B., Platz, A., & Ringborg, U. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00376.x · Cited by 155
Self-citationFrequent alterations of Ras signaling pathway genes in sporadic malignant melanomas
REIFENBERGER, J., Knobbe-Thomsen, C. B., Sterzinger, A. A., Blaschke, B., Schulte, K. W., Ruzicka, T., & Reifenberger, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11722 · Cited by 146
Omholt, K., Karsberg, S., Platz, A., Kanter, L., Ringborg, U. K., & Hansson, J. (2002) · PubMed · Cited by 144
Self-citationUribe, P., Wistuba, I. I., & González, S. (2003) · American Journal of Dermatopathology · doi:10.1097/00000372-200310000-00001 · Cited by 142
High BRAF mutation frequency does not characterize all melanocytic tumor types
Saldanha, G. S., Purnell, D., Fletcher, A., Potter, L., Gillies, A., & Pringle, J. H. (2004) · International Journal of Cancer · doi:10.1002/ijc.20325 · Cited by 141
Tumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited
Gray‐Schopfer, V. C., Karasarides, M., Hayward, R., & Marais, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1880 · Cited by 135
Ugurel, S., Thirumaran, R. K., Bloethner, S., Gast, A., Sucker, A., Mueller-Berghaus, J., Rittgen, W., Hemminki, K., Becker, J. C., Kumar, R., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000236 · Cited by 134
Sekiya, T., Fushimi, M., Hori, H., Hirohashi, S., Nishimura, S., & Sügimura, T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4771 · Cited by 127
Akslen, L. A., Angelini, S., Straume, O., Bachmann, I. M., Molven, A., Hemminki, K., & Kumar, R. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23788.x · Cited by 111
Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells
Eskandarpour, M., Kiaii, S., Zhu, C., Castro, J., Sakko, A. J., & Hansson, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20873 · Cited by 110
Self-citationPoint mutations in the N-ras oncogene in malignant melanoma and congenital naevi
CARR, J., & Mackie, R. M. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08460.x · Cited by 99
The molecular basis of cell cycle and growth control
Stein, G. S. (1999) · Cited by 95
Jafari, M., Papp, T., Kirchner, S., Kiener, U., Henschler, D., Burg, G., & Schiffmann, D. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202725 · Cited by 94
Activation of N-ras in a Human Melanoma Cell Line
Padua, R. A., Barrass, N. C., & Currie, G. A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.582-585.1985 · Cited by 92
Detection of B-RAF and N-RAS mutations in human melanoma
Goydos, J. S., Mann, B., Kim, H. J., Gabriel, E. M., Alsina, J., Germino, J. F., Shih, W. J., & Gorski, D. H. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.10.032 · Cited by 91
Could BRAF Mutations in Melanocytic Lesions Arise from DNA Damage Induced by Ultraviolet Radiation?
Thomas, N. E., Berwick, M., & Cordeiro‐Stone, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700458 · Cited by 91
Kumar, R., Angelini, S., & Hemminki, K. (2003) · Oncogene · doi:10.1038/sj.onc.1206909 · Cited by 90
Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations
Eskandarpour, M., Hashemi, J., Kanter, L., Ringborg, U. K., Platz, A., & Hansson, J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.790 · Cited by 86
Self-citationHusain, Z., Pathak, M. A., Flotte, T. J., & Wick, M. M. (1991) · PubMed · Cited by 82
Nappi, A. J., & Vass, E. (1996) · Melanoma Research · doi:10.1097/00008390-199610000-00001 · Cited by 81
Differential oncogenic potential of activated RAS isoforms in melanocytes
Whitwam, T., VanBrocklin, M. W., Russo, M. E., Haak, P. T., Bilgili, D., Resau, J. H., Koo, H.-M., & Holmen, S. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210239 · Cited by 81
Ultraviolet Immunosuppression: Mechanisms and Consequences
Hanneman, K. K., Cooper, K. D., & Baron, E. D. (2006) · Dermatologic Clinics · doi:10.1016/j.det.2005.08.003 · Cited by 74
Lang, J., & MacKie, R. M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23833.x · Cited by 71
Shukla, V. K., Hughes, D. C., Hughes, L. E., McCormick, F. P., & Padua, R. A. (1989) · PubMed · Cited by 70
Törmänen, V., & Pfeifer, G. P. (1992) · PubMed · Cited by 70
Biallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival
Grafström, E., Egyházi, S., Ringborg, U. K., Hansson, J., & Platz, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1731 · Cited by 61
Self-citationTandem BRAF Mutations in Primary Invasive Melanomas
Thomas, N. E., Alexander, A. A., Edmiston, S. N., Parrish, E., Millikan, R. C., Berwick, M., Groben, P. A., Ollila, D. W., Mattingly, D., & Conway, K. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22523.x · Cited by 58
(1992) · PubMed · Cited by 57
Joshi, P. C., Carraro, C., & Pathak, M. A. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90480-3 · Cited by 55
Activation of N-ras induced by ultraviolet irradiation in vitro.
van der Lubbe, J. L. M., Rosdorff, H. J. M., Bos, J. L., & van der Eb, A. J. (1988) · PubMed · Cited by 54
Site-specific DNA damage induced by UVA radiation in the presence of endogenous photosensitizer.
Ito, K., & Kawanishi, S. (1997) · PubMed · Cited by 49
A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
Demunter, A., Ahmadian, M. R., Libbrecht, L. J., Stas, M., Baens, M., Scheffzek, K., Degreef, H. J., Wolf‐Peeters, C. D., & van den Oord, J. J. (2001) · PubMed · Cited by 48
Christensen, C., & Guldberg, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208758 · Cited by 48
Sivertsson, Å., Platz, A., Hansson, J., & Lundeberg, J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.12.2164 · Cited by 40
Self-citationDetection of mutations in the mitogen-activated protein kinase pathway in human melanoma.
Alsina, J., Gorsk, D. H., Germino, F. J., Shih, W. J., Lu, S., Zhang, Z., Yang, J., Hait, W. N., & Goydos, J. S. (2003) · PubMed · Cited by 39
Platz, A., Ringborg, U. K., Månsson‐Brahme, E., & f, B. L. (1994) · Melanoma Research · doi:10.1097/00008390-199406000-00005 · Cited by 36
Self-citationPlatz, A., Ringborg, U. K., Grafström, E., Höög, A., & Lagerlöf, B. (1995) · Melanoma Research · doi:10.1097/00008390-199504000-00005 · Cited by 24
Self-citationT1799A BRAF Mutation is Common in PUVA Lentigines
Lassacher, A., Worda, M., Kaddu, S., Heitzer, E., Legat, F. J., Massone, C., Cerroni, L., Kerl, H., Ananthaswamy, H. N., & Wolf, P. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700250 · Cited by 18
Deichmann, M., Thome, M., Benner, A., & Näher, H. (2004) · Oncology · doi:10.1159/000079490 · Cited by 15
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma
Lupetti, R., Sensi, M., Mortarini, R., Anichini, A., Clemente, C., & Parmiani, G. (1994) · Melanoma Research · doi:10.1097/00008390-199402000-00003 · Cited by 10
Cited by
Eggermont, A. M., Spatz, A., & Robert, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60802-8 · Cited by 548
Capper, D., Preusser, M., Habel, A., Sahm, F., Ackermann, U., Schindler, G., Pusch, S., Mechtersheimer, G., Zentgraf, H., & von Deimling, A. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0841-z · Cited by 472
Lee, J.-H., Choi, J.-W., & Kim, Y.-S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10185.x · Cited by 419
Oberholzer, P. A., Kee, D., Dziunycz, P., Sucker, A., Kamsukom, N., Jones, R., Roden, C., Chalk, C. J., Ardlie, K., Palescandolo, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.7680 · Cited by 386
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Landi, M. T., Zhao, Y., Rotunno, M., Koshiol, J., Liu, H., Bergen, A. W., Rubagotti, M., Goldstein, A. M., Linnoila, I., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1736 · Cited by 321
Metadata
- Authors
- Platz, A., Egyhazi, S., Ringborg, U., & Hansson, J.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2007-12-28
- Volume
- 1
- Issue
- 4
- Pages
- 395-405
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2070871778
- Cited by
- 260
- References
- 88
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.